Akouos

Acquired

Healthy hearing available to all

Boston, United States · Founded 2016 · $162.5M raised

Employees
51–200
Founded
2016
Business Model
B2B
Website
akouos.com
Total Funding
$162.5M
Last Round
$105.0M Series BMar 2020
Rounds
3
Acquisition Date
Oct 2022

About

Akouos is a precision genetic medicine company developing gene therapies to restore, improve, and preserve high-acuity physiologic hearing for people with disabling hearing loss. Focused on inner ear delivery and AAV gene therapy platforms, it was acquired by Eli Lilly. Targets genetic forms of hearing loss affecting 466 million worldwide.

Summary

Akouos is a Biotech company based in Boston, United States, founded in 2016. It has raised $162.5M in total across 3 rounds, most recently a $105.0M Series B round in Mar 2020. Investors include 5AM Ventures, New Enterprise Associates and Eli Lilly.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionOct 2022

Sign up to see all 5 rounds

Seed through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Akouos on Indexed.vc
<a href="https://indexed.vc/companies/akouos"><img src="https://indexed.vc/api/badge/company/akouos" alt="Akouos on Indexed.vc" width="260" height="76" /></a>